It is related to tumor progression, metastasis, drug resistance, and promotes apoptosis at mitochondria by activating proteins Bax and Bak and by inhibiting the anti-apoptotic proteins Bcl-XL, Bcl-2, and Mcl-1 (Chi et al., 2020). The gene discussed is BCL2L1; the disease is neoplasm.